Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

SRD-001

Aliases
AAV1/SSERCA2a

2 clinical trials

5 indications

Indication
DMD-Associated Dilated Cardiomyopathy
Indication
Heart Failure
Indication
Congestive Heart Failure
Indication
systolic
Indication
Heart Failure With Reduced Ejection Fraction
Clinical trial
A Phase 1b, Open-Label, Controlled Trial Evaluating the Safety and Efficacy of SRD-001 (AAV1/SERCA2a) in Subjects With Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Status: Not yet recruiting, Estimated PCD: 2027-02-01
Clinical trial
A Phase 1/2 Trial of the Safety and Efficacy of SRD-001 (AAV1/SERCA2a) in Subjects With Heart Failure With Reduced Ejection Fraction
Status: Recruiting, Estimated PCD: 2025-12-31